Evidence map›Paper›PMID 32808079›Full record

ArticleEuropean journal of nuclear medicine and molecular imaging2021

CT abnormalities evocative of lung infection are associated with lower

Achraf Bahloul, Caroline Boursier, Hélène Jeulin, Laëtitia Imbert, Damien Mandry, Gilles Karcher, Pierre-Yves Marie, Antoine Verger

Open access · bronzeAbstract read
In one paragraph

Article in European journal of nuclear medicine and molecular imaging, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.2field-weighted citation impact, top 37% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 9 citations in OpenAlex.

  1. Contribution ofCurrent issues in molecular biology · 2025
    Review
  2. Article
  3. Article
  4. Positron emission tomography in the COVID-19 pandemic era.European journal of nuclear medicine and molecular imaging · 2021
    Review
  5. Role of 2-[Pharmaceuticals (Basel, Switzerland) · 2020
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Achraf BahloulLorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Caroline BoursierLorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Hélène JeulinLorraine University, Department of Virology, CHRU Nancy, F-54000, Nancy, France.
Laëtitia ImbertLorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Damien MandryLorraine University, IADI, INSERM U1254, F-54000, Nancy, France.
Gilles KarcherLorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Pierre-Yves MarieLorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France.
Antoine VergerLorraine University, Department of Nuclear Medicine and Nancyclotep Imaging Platform, CHRU Nancy, F-54000, Nancy, France. a.verger@chru-nancy.fr.ORCID 0000-0003-2194-0328
Inserm · FRUniversité de Lorraine · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

purposeCT signs that are evocative of lung COVID-19 infections have been extensively described, whereas

methodsTwenty-two consecutive patients referred for routine

resultsEleven patients were confirmed to be affected by COVID-19 (COVID+), whereas the other eleven patients were not (COVID-) and were predominantly suspected of having bacterial pneumonia. CT abnormalities were not significantly different between COVID+ and COVID- groups, although trends toward larger CT abnormalities (p = 0.16) and lower rates of consolidation patterns (0.09) were observed in the COVID+ group. The maximal standardized uptake values (SUV

conclusionAmong CT abnormalities evocative of lung infection, those related to COVID-19 are associated with a more limited

Indexed as

Fluorodeoxyglucose F18RadiopharmaceuticalsAgedAged, 80 and overCOVID-19COVID-19 Nucleic Acid TestingCOVID-19 Serological TestingDiagnosis, DifferentialFemaleHumansLungMaleMiddle AgedPositron Emission Tomography Computed TomographyFluorodeoxyglucose F18Radiopharmaceuticals18F-FDG-PETCOVID-19CTLung infectionSerological tests

Identifiers

PMID32808079
PMCPMC7431215
OpenAlexW3049314755

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.